Market Overview

According to MarketGenics, the global Personalized Medicine Market was valued at USD 484.1 billion in 2025 and is projected to reach USD 1,006.2 billion by 2035, registering a CAGR of 7.6% during the forecast period. The market is expanding as genomic sequencing, biomarker discovery, targeted therapies, pharmacogenomics, companion diagnostics, and AI-driven healthcare analytics enable treatment strategies tailored to individual patient characteristics. Oncology is the leading application segment, accounting for approximately 42% of the market in 2025.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/personalized-medicine-market-00494

Market Growth Drivers

Major growth drivers include advances in next-generation sequencing (NGS), genomic testing, biomarker discovery, pharmacogenomics, and targeted drug development. The increasing prevalence of cancer, cardiovascular diseases, and rare genetic conditions is strengthening demand for patient-specific treatment approaches. In addition, the integration of artificial intelligence, big-data analytics, multi-omics, companion diagnostics, and digital health platforms is improving patient selection, disease-risk assessment, clinical decision-making, and personalized therapy development.

Key Players

The competitive landscape is moderately consolidated, with the top five players accounting for more than 40% of the market share in 2025. Key players identified by MarketGenics include Abbott Laboratories, Agilent Technologies, Biogen, Caris Life Sciences, Danaher, Exact Sciences, F. Hoffmann-La Roche, Foundation Medicine, GE HealthCare, Guardant Health, Illumina, Natera, QIAGEN, Tempus AI, Thermo Fisher Scientific, and Veracyte. Competition is focused on genomic sequencing, precision diagnostics, companion diagnostics, biomarker testing, targeted therapies, and AI-enabled precision healthcare solutions.

Regional Insights

North America leads the global Personalized Medicine Market and is identified by MarketGenics as the most attractive region, supported by advanced healthcare systems, strong genomics research infrastructure, high healthcare spending, widespread adoption of precision diagnostics, and established biotechnology and pharmaceutical ecosystems. Asia Pacific is experiencing the fastest growth, driven by expanding genomic research programs, increasing healthcare digitization, growing genetic-testing awareness, and government-backed precision-medicine initiatives in countries such as China, Japan, and India. Europe is also advancing through investments in genomic medicine, targeted therapies, and precision healthcare infrastructure.

Related Reports:

AI Agents Market

Penetration Testing as Service Market

AI-powered Analytics Market

Soil Conditioners Market

Peptide Stabilization Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: [email protected]
Website: https://marketgenics.co